Social support, social network size, social strain, stressful life events, and coronary heart disease in women with type 2 diabetes: A cohort study based on the women’s health initiative by Jonasson, J.M. et al.
Social Support, Social Network
Size, Social Strain, Stressful Life
Events, and Coronary Heart
Disease in Women With Type 2
Diabetes: A Cohort Study Based on
the Women’s Health Initiative
Diabetes Care 2020;43:1759–1766 | https://doi.org/10.2337/dc19-2065
OBJECTIVE
Westudiedassociationsbetweensocial support, social networksize, social strain,or
stressful life events and risk of coronary heart disease (CHD) in postmenopausal
women with type 2 diabetes.
RESEARCH DESIGN AND METHODS
From the Women’s Health Initiative, 5,262 postmenopausal women with type 2
diabetes at baseline were included. Cox proportional hazards regression models
adjusted for demographics, depressive symptoms, anthropometric variables, and
lifestyle factorswere used to examine associations between social factors and CHD.
RESULTS
A total of 672 case subjects with CHD were observed during an average 12.79 (SD
6.29) years of follow-up. There was a significant linear trend toward higher risk of
CHDas thenumberof stressful life events increased (P for trend50.01; hazard ratio
[HR] [95% CI] for the third and fourth quartiles compared with first quartile: 1.27
[1.03–1.56] and 1.30 [1.04–1.64]). Being married or in an intimate relationship was
related to decreased risk of CHD (HR 0.82 [95% CI 0.69–0.97]).
CONCLUSIONS
Among postmenopausal women with type 2 diabetes, higher levels of stressful life
events were associated with higher risk of CHD. Experience of stressful life events
might be considered as a risk factor for CHD among women with type 2 diabetes.
Diabetes is oneof themost commonchronic diseases globally. Currently, 415million
people worldwide have diabetes, which is expected to increase to 615 million by
2040 (1). Type 2 diabetes accounts for around 90% of all diabetes (1). The major
threats to the health of people with type 2 diabetes are associated conditions, such
as cardiovascular diseases (CVDs), retinopathy, nephropathy, and neuropathy.
CVD, especially coronary heart disease (CHD), is one of the leading causes of
mortality from type 2 diabetes (2). Findings from a meta-analysis of 102 prospective
studies showed that people with diabetes have twice the risk of CHD compared with
those without diabetes (3). Lifestyle factors (e.g., physical inactivity, smoking,
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unhealthydiet,andalcoholconsumption),
metabolic factors (e.g., hypertension and
obesity), and psychosocial factors (e.g.,
depression) have been identified as po-
tential risk factors for CVD among people
with type 2diabetes (3). Self-management
of blood glucose is vital for the pre-
vention of CVD in people with type 2
diabetes (4). Postmenopausal women
with type 2 diabetes have a higher risk of
CVD and worse prognosis after a CVD
event compared with men with type 2
diabetes (5), suggesting a particular
need to better understand risk factors
for CVD in women.
Socialepidemiological researchandthe-
ory suggest the importance of social re-
lationship factors in health outcomes. For
example, Berkman et al. (6) proposed a
causal process of social relationships on
biopsychosocial components of health
through several mechanisms, including
provision of social support, social influ-
ence, social engagement and attachment,
and access to resources and material
goods. According to the stress-buffering
hypothesis (7), social support and social
network moderate the association be-
tween stress and health outcomes. Ac-
cording to the stress-exacerbating
hypothesis, social strain moderates the
association between stress and health out-
comes.Social strainandstressful lifeevents
are the negative aspects of social relation-
ships (6) and had been recognized as the
risk factors for CHD in the general pop-
ulation. In terms of buffering factors,
larger social network size was found
tobe related to lower all-causemortality
risk amongolder adultswithdiabetes (8).
Earlier cross-sectional studies amongpeo-
ple with type 2 diabetes showed that a
smaller social network was related to
higher risk of CVD (9). No significant
associations were observed between so-
cial support and risk factors for CVD, such
as hypertension and smoking, in one
cross-sectional study (10). Positive asso-
ciations between social support or social
network and the self-management of di-
abetes were reported in other studies
(11–14). Associations of social relation-
ship variables with CHD among people
with diabetes have not been examined
prospectively.
The theoretical framework of this study
isbasedonthestress-bufferingandstress-
exacerbating hypotheses, which involve
testing bothnoninteraction (main effects)
and interaction models. In general, the
noninteraction model will test the main
effects of stress, social support, social
network, and social strain on health out-
comes. The interaction models will test
the stress-buffering hypothesis (interaction
between social support or social network
and stressful life events) and stress-
exacerbating hypothesis (interaction be-
tween social strain and stressful life events).
This large-scale epidemiological study will
be basedondata fromtheWomen’sHealth
Initiative (WHI). Specifically, to test the
stress-buffering hypothesis, the following
question will be answered in the current
study: does social support or social net-
work moderate the association between
stressful lifeevents and theoccurrenceof
CHD? To test the stress-exacerbating hy-
pothesis, this studywill answer: does social
strain moderate the association between
stressful life events and the risk of CHD?
RESEARCH DESIGN AND METHODS
Study Design and Settings
This was a cohort study based on post-
menopausalwomenwith type 2diabetes
from the WHI. The WHI included three
separate but overlapping clinical trials
(CTs) and an observational study (OS)
investigating the major causes of mor-
bidity and mortality among postmeno-
pausalwomen(15). The study isdescribed
in greater detail elsewhere (16–20). Briefly,
161,808postmenopausalwomenaged50–
79 years were recruited from 40 clinical
centers throughout the United States be-
tween 1993 and 1998. Women were en-
rolled into one or more of three CTs,
including a hormone therapy trial, dietary
modification trial, and calcium and vitamin
D supplementation trial, or an OS. Partic-
ipants in the OS included 93,676 women
who were screened for the CT but were
ineligible or unwilling to participate in the
WHI CT or were recruited through a direct
invitation for the OS. The WHI main study
ended on 31 March 2005 with a closeout
date for data collection on 8 April 2005.
Overall, 82.4% of participants in the CT and
72.9% of participants in the OS consented
to join the first Extension Study and were
additionally followed from 2005 to 2010.
There were 85.2% of women in the CT and
88.2%ofwomenintheOScomponentfrom
the first Extension Study who consented
to join the secondExtensionStudy (2010–
2020) for additional follow-up. Non-
Latinawhitewomenand youngerwomen
were more likely to consent to extension
studies. The study was approved by
Institutional ReviewBoards at all 40 clinical
centers and at the coordinating center. All
participants provided written informed
consent.
Participants
The inclusion criterion was women with
type 2 diabetes at the baseline of WHI.
According tobaselinemeasurement using
a validated definition for type 2 diabetes
(21), a participantwas considered to have
type 2 diabetes if she answered “yes” to
the question, “Did a doctor ever say that
you had sugar diabetes or high blood
sugar when you were not pregnant?,”
was diagnosed after 21 years of age, and
had not been hospitalized for diabetic
coma.Theexclusioncriteriawerewomen




Based on previously validated measure-
ments collected at baseline, social support
(22), social network size (23), social strain
(24), andstressful lifeevents (25)were the
main exposure variables and were ana-
lyzed separately to test our hypotheses:
Social support: Social support was con-
structed based on nine questions re-
garding how often participants could
access each type of support (22). Items
are shown in Supplementary Table 1A.
Subscales of social support were con-
structed from different questions and
included emotional/information sup-
port, affection support, tangible sup-
port, and positive social interaction
(Supplementary Table 1B). Five-point
scales (range from1, noneof the time,
to 5, all of the time) were used for each
answer. The total scale score ranged
from 9 to 45, with a higher score
representing greater social support.
Social network size: Information on the
components of social network (i.e.,
being married or in an intimate re-
lationship, club ties, religious ties, and
number of first-degree relatives) was
collected. A social network size index
was developed based on these com-
ponents (23).Scoresontheindexranged
from0 to5,with 1point each formarital
status (married/in an intimate relation-
ship vs. not), club ties (attended clubs/
lodges/groups last month; yes vs. no),
religious ties (yes vs. no), and 0–2 points
based on the tertile of ties to supportive
relatives (0points for,5 ties, 1point for
5–7 ties, and 2 points for .7 ties).
Social strain: Social strain is a construct
based on four items selected from the
original seven-itemscaledevelopedby
Antonucci et al. (24) (Supplementary
Table 2). Each item is coded from
1 (none) to 5 (all), with the total score
ranging from 4 to 20 and higher scores
indicating greater social strain.
Stressful life events: Eleven items were
used to assess stressful life events
that occurred in the year prior to WHI
baseline (25) (Supplementary Table 3).
The responses were: no/did not occur;
yes, and it upset me but not toomuch;
yes, it upsetmemoderately (medium);
and yes, it upset me very much. The
total score ranges from 0 to 33, with
higher scores representing greater
number and severity of upsetting
events.
Outcomes
The primary outcome was first occur-
rence of CHD during WHI follow-up. The
occurrence of CHD was defined as first
occurrence of clinical myocardial infarc-
tion (MI), definite silent MI, or death due
to definite CHD or possible CHD. Out-
comes were adjudicated by physicians
following diagnostic standards for CT and
OS through 2010 (26). From 2010, car-
diovascular outcomes were adjudicated
byphysicians for the subset that included
all former hormone trial participants
and all African American and Hispanic
participants.
Covariates
We considered the following poten-
tial confounders: baseline age, race/
ethnicity (American Indian or Alaska
Native, Asian or Pacific Islander, black
or African American, Hispanic/Latina,
non-Hispanic white, or other), educa-
tional level (high school or less, some
college/technical training, college or
some postcollege, and master’s level




study cohort (participation in OS or CT
and different treatment assignments for
all three CTs), hypertension (never, un-
treated, or treated), a history of high
cholesterol requiring pills (no or yes),
and a family history of MI; depressive
symptoms were assessed using the eight-
itemBurnamscale, resulting inacomposite
scale ranging from 0 to 1; scores were
categorized into none, mild, or moderate
based on previously established cut points
of 0.009 and 0.06 (27). Additional cova-
riates included physical activity (assessed
as total energy expenditure from recrea-
tional physical activity and classified as,5,
5 to ,10, 10 to ,20, 20 to ,30, or $30
metabolic equivalent [MET] values/week),
smokinghistory(never, former,orcurrent),
alcohol consumption (nondrinker, past
drinker, current and less than one drink
per week, current and one to seven
drinks per week, current and at least
seven drinks per week, or current and
less than one drink per month), BMI
(established by clinical height/weight
assessment), waist-to-hip ratio (WHR),
and healthy eating index (HEI)-2005 score
(quartile) obtained from the Food Fre-
quency Questionnaire. HEI-2005 is
a measure of diet quality that assesses
conformance to the 2005 dietary guide-
lines for Americans (28).
Statistical Analysis
Both descriptive and inferential statis-
tical analyses were performed. Each
constructed exposure variable was cat-
egorized into quartiles. We also ana-
lyzed the scores on the components of
social support as mentioned above.
Means and SDs were used to describe
baseline continuous variables, and fre-
quencies andproportionswerepresented
for categorical variables. Differences by
exposure variables were evaluated using
ANOVA for continuous variables and x2
tests for categorical variables. We used
Cox proportional hazards models to eval-
uate associations between each of the
main exposures and the occurrence of
CHD, with results presented as hazard
ratios (HRs)and95%CIs. Survival timewas
calculatedas thedurationfromthedateof
enrollment until the first occurrence of
CHD, date of death, or 31 March 2018,
whichever occurred first. In the multivari-
able models, we adjusted for potential
covariates listed above in progressively
adjustedmodels. Inmodel 1, we adjusted
for age, ethnicity, education, family in-
come, family history of MI, hypertension,
history of high cholesterol requiring pills,
and study cohort (CT or OS and different
assignmentsforCTs). Inthesecondmodel,
we adjusted additionally for depressive
symptoms. Depressive symptoms are
common among people with type 2 di-
abetes (29). These were shown to be
related to the social support (30) and the
occurrence of complications in diabetes
(31). The third model additionally ad-
justed for major modifiable lifestyle
factors including BMI, WHR, dietary
quality, physical activity, smoking his-
tory, and alcohol consumption. Trend
analyses were performed by entering
the original scales of the main exposure
variables as continuous variables in the
models. To test the stress-buffering and
stress-exacerbating hypotheses, inter-
action terms between social support
or social network or social strain and
stressful life events were added to the
models. P values were two-sided and
considered significant at values ,0.05.
Statistical analyses were performed us-
ing SAS version 9.4 (SAS Institute, Cary,
NC).
RESULTS
Based on our inclusion and exclusion
criteria, 9,303 women with type 2 di-
abetes at the baseline of WHI were first
identified. Among these 9,303 women,
we excluded 2,498womenwhohadCVD
at baseline, 962 womenwho had cancer
(except nonmelanoma skin cancer) at
baseline, and 581 women with missing
information on the main exposures.
Thus, the current study included 5,262
women with type 2 diabetes.
Therewere672case subjectswithCHD
during a mean follow-up of 12.79 (SD
6.29) years. Table 1 shows the baseline
characteristics of the study population
according to the occurrence of CHD.
Compared with women with type 2 di-
abeteswhodid not develop CHD,women
who developed CHD were older, had
lower levels of education, had lower in-
come, less often reported minority racial
background, had lower total energy ex-
penditure from recreational physical ac-
tivity (MET-hperweek), hadgreaterWHR,
had more family history of MI, and had
more hypertension (all P , 0.05). There
were no significant differences in HEI,
BMI, smoking history, alcohol consump-
tion, history of high cholesterol requiring
pills, or depressive symptoms between
women who did or did not develop CHD.
Table 2 shows the results of Cox pro-
portional hazards models on the main
effect of social support, social network
size, social strain, and stressful life events
on the risk of CHD in women with type 2
diabetes. Only the main association
between stressful life events and risk
Table 1—Baseline characteristics of participants by the occurrence of CHD
CHD
No Yes
Age at baseline (years)* 4,590 (63.5 [6.8]) 672 (65.8 [6.7])
Family income
Missing 312 (6.8) 41 (6.1)
,$20,000 1,126 (24.5) 211 (31.4)
$20,000–34,999 1,187 (25.9) 190 (28.3)
$35,000–49,999 864 (18.8) 112 (16.7)
$50,000–74,999 684 (14.9) 76 (11.3)
$75,000–99,999 248 (5.4) 24 (3.6)
$100,000–149,999 117 (2.5) 15 (2.2)
$$150,000 52 (1.1) 3 (0.4)
Ethnicity
Missing 13(0.3) 2 (0.3)
American Indian or Alaskan Native 47 (1.0) 5 (0.7)
Asian or Pacific Islander 229 (5.0) 20 (3.0)
Black or African American 929 (20.2) 125 (18.6)
Hispanic/Latino 324 (7.1) 20 (3.0)
White (not of Hispanic origin) 2,980 (64.9) 492 (73.2)
Other 68 (1.5) 8 (1.2)
Educational levels
Missing 34 (0.7) 1 (0.1)
High school diploma or less 1,401 (30.5) 236 (35.1)
Some college or technical training 1,814 (39.5) 252 (37.5)
College graduate or some postcollege 763 (16.6) 103 (15.3)
Master’s degree or higher 578 (12.6) 80 (11.9)
BMI (kg/m2)* 4,562 (31.9 [6.7]) 668 (32.4 [6.7])
WHR* 4,572 (0.87 [0.08]) 669 (0.88 [0.079])
Total HEI-2005 score* 4,590 (68.2 [10.6]) 671 (67.5 [10.2])
Total energy expenditure from recreational physical activity
(MET-h/week)* 4,391 (9.7 [12.0]) 627 (8.2 [11.4])
Smoking habit
Missing 64 (1.4) 15 (2.2)
Never smoked 2,424 (52.8) 335 (49.9)
Past smoker 1,810 (39.4) 269 (40.0)
Current smoker 292 (6.4) 53 (7.9)
Alcohol consumption
Missing 39 (0.8) 9 (1.3)
Nondrinker 783 (17.1) 127 (18.9)
Past drinker 1,721 (37.5) 258 (38.4)
,1 drink/month 636 (13.9) 98 (14.6)
,1 drink/week 760 (16.6) 98 (14.6)
1 to ,7 drinks/week 480 (10.5) 63 (9.4)
$7 drinks/week 171 (3.7) 19 (2.8)
Relative had MI
Missing 296 (6.4) 37 (5.5)
No 1,983 (43.2) 238 (35.4)
Yes 2,311 (50.3) 397 (59.1)
Depressive symptoms
None 3,266 (71.2) 487 (72.5)
Mild 680 (14.8) 91 (13.5)
Moderate 644 (14.0) 94 (14.0)
High cholesterol requiring pills ever
Missing 270 (5.9) 54 (8.0)
No 3,352 (73.0) 466 (69.3)
Yes 968 (21.1) 152 (22.6)
Hypertension
Missing 263 (5.7) 57 (8.5)
Never hypertensive 1,780 (38.8) 208 (31.0)
Untreated hypertensive 433 (9.4) 74 (11.0)
Treated hypertensive 2,114 (46.1) 333 (49.6)
Data are n (%) unless otherwise indicated. *Total number (mean [SD]).
of CHD was statistically significant in
models 1–3. In model 1, women in the
third and fourth quartiles of stressful life
events had significantly increased risk
for CHD compared with women in the
lowest quartile (HRs [95% CI] were 1.28
[1.05–1.57] and 1.33 [1.07–1.66], respec-
tively). In model 2, similar increased risks
of CHD were observed for the third and
fourth quartiles versus the lowest quar-
tile (HRs [95% CI] were 1.29 [1.05–1.59]
and 1.34 [1.07–1.69], respectively). In
model 3, the HRs remained significant
(HRs [95% CI] were 1.27 [1.03–1.56] and
1.30 [1.04–1.64], respectively). The
third quartile of social network size
had significantly lower risk of CHD com-
pared with the lowest quartile in models
1, 2, and 3 (HRs [95%CI] were 0.73 [0.57–
0.93], 0.73 [0.58–0.93], and 0.76 [0.59–
0.97], respectively). The HRs (95% CI) for
the fourth quartile of social network size
in these three models were 0.84
(0.66–1.06), 0.84 (0.66–1.07), and 0.88
(0.69–1.12), respectively. No significant
associations between social support and
social strain and risk of CHD were ob-
served in any models.
Table 3 presents the main effect of
components of social network size and
the risk of CHD in women with type 2
diabetes. Beingmarried or in an intimate
relationship was related to decreased
risk of CHD compared with not being
married or in an intimate relationship in
models 1, 2, and 3 (HRs [95% CI] were
0.80 [0.67–0.95], 0.81 [0.68–0.96], and
0.82 [0.69–0.97], respectively). There
were no significant associations between
other components and the risk of CHD.
To further examine the specific role of
stressful life events in the context of
other social variables, we further tested
the changes of the effect estimate of
associationsbetweenstressful lifeevents
and the risk of CHD inwomenwith type 2
diabetes by adding social support, social
network size, or social strain to model 3.
However, the effect estimates remained
the same for these analyses.
Table 4 shows the main effect of sub-
scales of social support and the associated
risk of CHD in women with type 2 diabetes.
Compared with women with type 2 di-
abetes who reported “none of the time”
to the affection support subscale item
“someone to love you andmake you feel
wanted,” women who reported some
level of support such as “a little of the
time” to “all of the time” had a lower risk
of CHD.
In our analysis of interaction models,
we did not find an interaction between
stressful life events and social support
(interaction term P5 0.27). Similarly, no
interactions were observed between
stressful life events and social network
size (P 5 0.14). No interactions were
observed between stressful life events
and social strain (P 5 0.88).
CONCLUSIONS
In this cohort study among postmeno-
pausal women with type 2 diabetes who
participated in the WHI, higher levels of
Table 2—Associations between social support, social network, social strain, and stressful life events and risk of CHD in women
with type 2 diabetes
Number of cases Model 11 Model 22 Model 33
Social support4
Q1 192 Reference Reference Reference
Q2 160 0.95 (0.77–1.18) 0.96 (0.77–1.19) 0.99 (0.80–1.23)
Q3 186 0.97 (0.79–1.19) 0.98 (0.79–1.21) 1.02 (0.82–1.26)
Q4 134 0.93 (0.74–1.17) 0.94 (0.74–1.19) 1.00 (0.79–1.26)
P for trend 0.23 0.29 0.68
Social network size4
Q1 116 Reference Reference Reference
Q2 192 0.96 (0.76–1.21) 0.96 (0.76–1.21) 0.97 (0.77–1.23)
Q3 173 0.73 (0.57–0.93) 0.73 (0.58–0.93) 0.76 (0.59–0.97)
Q4 191 0.84 (0.66–1.06) 0.84 (0.66–1.07) 0.88 (0.69–1.12)
P for trend 0.03 0.03 0.11
Social strain4
Q1 175 Reference Reference Reference
Q2 192 1.11 (0.90–1.37) 1.11 (0.90–1.37) 1.09 (0.88–1.35)
Q3 141 1.02 (0.81–1.28) 1.01 (0.80–1.26) 0.99 (0.78–1.24)
Q4 164 1.09 (0.87–1.36) 1.07 (0.86–1.34) 1.00 (0.79–1.25)
P for trend 0.41 0.51 0.96
Stressful life events4
Q1 164 Reference Reference Reference
Q2 84 1.00 (0.77–1.30) 1.00 (0.77–1.31) 0.97 (0.74–1.28)
Q3 239 1.28 (1.05–1.57) 1.29 (1.05–1.59) 1.27 (1.03–1.56)
Q4 185 1.33 (1.07–1.66) 1.34 (1.07–1.69) 1.30 (1.04–1.64)
P for trend 0.01 ,0.001 0.01
DataareHR (95%CI) unlessotherwise indicated. 1Adjusted for ageatbaseline, race/ethnicity (American IndianorAlaskaNative,AsianorPacific Islander,
black or African American, Hispanic/Latino, non-Hispanic white, and other), education (high school or less, some college/technical training, college or
some postcollege, and master’s degree or higher), family income (,$20,000, $20,000–34,999, $35,000–49,999, $50,000–74,999, $75,000–99,999,
$100,000–149,999, and$$150,000), family history ofMI (no or yes), hypertension (never, untreated, or treated), a history of high cholesterol requiring
pills ever (no or yes), and different study cohorts (participation inOS or CTs anddifferent treatment assignments for all three CTs). 2Further adjusted for
depressive symptoms. 3Further adjusted for BMI, WHR, smoking (never, former, or current), alcohol intake (nondrinker, past drinker, current and,7
drinks/week, or current and$7drinks/week), physical activity (,5, 5 to,10, 10 to,20, 20 to,30, or$30MET-h/week), andquality of diet (quartile).
4Q1, Q2, Q3, and Q4 for each exposure represent first, second, third, and fourth quartile, respectively.
stressful life events were associated with
higher risk of CHD. The third quartile of
social network size was associated with a
lower risk of CHD. No main effects of
social support or social strain on the risk
of CHD were found. One component of
social network sizedbeing married or in
an intimate relationshipdwas associ-
ated with lower risk of CHD. There was
no evidence for stress-buffering effects
by social support or social network or a
stress-exacerbating effect by social
strain.
To the best of our knowledge, this is
the first study on the associations be-
tween social support, social network size,
social strain, and stressful life events
and the risk of CHD in postmenopausal
women with type 2 diabetes. An earlier
study based on the general population in
the WHI found that diabetes might be a
mediator for associations of both stress-
ful life events and social strain with CHD
(32). Earlier studies among people with
diabetes were cross-sectional in design
with relatively small sample sizes and
focused on only one social relationship
variable. One cross-sectional study based
on 797 individuals with diabetes in the
Maastricht Study found that smaller
social network size was associated with
increased risk of CVD (9).
Our interaction tests did not support
the stress-buffering and stress-exacerbating
hypotheses. There could be several possible
reasons for this. First, social support or
social strain may, in fact, not buffer or
exacerbate stress aswemeasured. There
are different forms of social support.
Each form of social support might be
specifically useful in buffering certain
types of stressful events (7). For exam-
ple, economic support from a friend may
be effective in the situation of tempo-
rary unemployment, but not effective in
the situation of loss of a pet. Second,
stressful life events, social support, so-
cial network size, and social strain were
all measured at baseline; we did not
capture changes over time that may
affect the outcome.
The observed associations between
recent stressful life events and risk of
CHD might operate through different
mechanisms. Stressful life events in the
past year at baseline may increase the
risk of CHD through inflammation and
endothelia dysfunction due to the stress-
induced dysregulation of the sympathetic
nervous system and the hypothalamic-
pituitary-adrenal axis (33,34). Stressful life
events could be related to less involve-
ment in diabetes care programs (35). The
higher level of stressful life events was
significantlyassociatedwith increased risk
of CHD in all three models. The effect
estimates in model 3 that controlled for
lifestyle factors, such as dietary quality
and physical activity, were similar to the
results in models 1 and 3. This indicates
that stressful life events were related to
increased risk of CHD independent of
health behaviors among women with
type 2 diabetes. It is possible that psy-
chophysiological factors associated with
exposure to a stressful life event, beyond
the event itself, may be a mechanism
affecting CHD risk in these women, and
this should be further evaluated in future
research. This may be relevant given that
themeasureof stressful life eventsused in
WHI not only reflected exposure to dif-
ferent types of events (e.g., exposure to
physical abuse, spouse died) but also the
degree of emotional distress (e.g., the
event “upset me very much”) associated
with the event. Interestingly, larger social
network size was significantly associated
with lower risk of CHD in models 1 and 2,
but not in model 3, in which there was
additional adjustment for lifestyle factors.
This result indicates that health behaviors,
such as physical activity and healthy diet,
might be mediators of the associations
between social network size and risk of
CHD.
Wedidnotfind significant associations
among social support, social strain, and
risk of CHD in women with type 2 di-
abetes. However, the third quartile of
social network size was associated with
lower risk of CHD. We speculate that this
moderate level of network sizemay offer
beneficial support, as opposed to lower
or higher levels of support that may
Table 3—Associations between components of social network and risk of CHD in women with type 2 diabetes
Number of cases Model 11 Model 22 Model 33
Married/in an intimate relationship
No 489 Reference Reference Reference
Yes 624 0.80 (0.67–0.95) 0.81 (0.68–0.96) 0.82 (0.69–0.97)
Attended clubs/lodges/groups last month
None 513 Reference Reference Reference
$1 600 1.01 (0.86–1.19) 1.01 (0.86–1.19) 1.04 (0.88–1.23)
Times attending religious services/church during
the past month
None 368 Reference Reference Reference
$1 745 0.89 (0.75–1.05) 0.88 (0.75–1.04) 0.90 (0.76–1.07)
Number of relatives
,5 402 Reference Reference Reference
5–8 268 1.00 (0.82–1.21) 1.01 (0.83–1.23) 1.01 (0.83–1.23)
.8 443 0.90 (0.75–1.09) 0.93 (0.77–1.11) 0.92 (0.76–1.11)
P for trend 0.28 0.30 0.40
DataareHR (95%CI) unlessotherwise indicated. 1Adjusted for ageatbaseline, race/ethnicity (American IndianorAlaskaNative,AsianorPacific Islander,
black or African American, Hispanic/Latino, non-Hispanic white, and other), education (high school or less, some college/technical training, college or
somepostcollege, andmaster’sdegreeorhigher), familyhistoryofMI (noor yes),hypertension (never,untreated,or treated), highcholesterol requiring
pills ever (no or yes), and different study cohorts (participation in OS or CTs and different treatment assignments for all three CTs). 2Further adjusted
for depressive symptoms. 3Further adjusted for BMI, WHR, smoking (never, former, or current), alcohol intake (nondrinker, past drinker, current
and ,7 drinks/week, or current and $7 seven drinks/week), physical activity (,5, 5 to ,10, 10 to ,20, 20 to ,30, and $30 MET-h/week), and
quality of diet (quartile).
reflect either social isolation or heavy
social obligations, respectively. In our
analysis on the subscales of social sup-
port and social network size, we found
that being married or in an intimate
relationship was related to decreased
risk of CHD. The protective effect of mar-
riage has been seen in other cohort studies
(36). Being married or in an intimate re-
lationship was related to regular monitor-
ing of blood glucose (37) and maintaining
blood glucose targets (38). Spouses and
partners could help women with type 2
diabetes with coping and decreasing the
distress that is related to diabetes, and it
could be that more proximal sources of
support (e.g., withwhom thewoman lives)
have a more direct impact on diabetes
management than other distal sources of
support. Other components of social net-
work size, such as club ties, religious ties,
and the numbers of relatives, were not
found to be significantly associated with
riskofCHD inwomenwith type2diabetes.
The subscales of social support, including
emotional/informational support, affection
support, tangible support, and positive
social interaction, were not significantly
associated with risk of CHD in women with
type 2 diabetes.
Our study strengths include the large
sample of women with type 2 diabetes
and long follow-up period. There was
detailed information on social factors
and potential confounding factors and
adjudicated information on CHD. How-
ever, some limitations in our study need
to be mentioned. First, the social net-
work size scale used only measures size
and does not measure the quality of the
social network. Furthermore, it did not
include the number of close friends.
However, we analyzed social strain,
which is an indicator of negative social
relationships. By analyzing total social
support and specific subscales, including
emotional/informational, affection, and
tangible and positive social interaction,
we were able to evaluate the quality
of the social network. Second, expo-
sures and potential confounding factors
were measured at WHI baseline. Some
misclassificationmightbe causedby lack
of examination of changes of these
factors during follow-up, which would
bias findings toward the null. Third, our
study results have limited generalizabil-
ity becauseour population consisted solely
of postmenopausal women with type 2
diabetes treatedwithdiabeticmedications
in the United States.We cannot generalize
our results to individuals with diabetes
treated with only diet and lifestyle mod-
ifications. Furthermore, women with sig-
nificant psychiatric conditions were
excluded from WHI. Thus, our results
cannot begeneralized topostmenopausal
women who experienced mental health
conditions that may have been exacer-
bated or triggered by stressful life events.
Fourth, the definition of diabetes was
based on self-reported information.
However, the validity of self-reported
diabetes is high according to validation
studies in the WHI when comparing self-
report with a gold standard based on
medical record review and with medica-
tion inventories (21,39).
Table 4—Associations between four subscales of social support and risk of CHD in women with type 2 diabetes
Number of cases Model 11 Model 22 Model 33
Emotional/information support subscale4
Q1 228 Reference Reference Reference
Q2 167 0.78 (0.64–0.96) 0.78 (0.64–0.96) 0.83 (0.68–1.03)
Q3 110 0.98 (0.77–1.24) 0.97 (0.77–1.23) 1.02 (0.80–1.30)
Q4 167 0.85 (0.69–1.05) 0.85 (0.69–1.05) 0.91 (0.74–1.13)
P for trend 0.11 0.15 0.45
Affection support subscale5
1 46 Reference Reference Reference
2 54 0.67 (0.45–1.00) 0.67 (0.45–1.00) 0.67 (0.45–1.01)
3 95 0.75 (0.52–1.08) 0.76 (0.53–1.09) 0.77 (0.53–1.11)
4 161 0.74 (0.53–1.04) 0.75 (0.53–1.05) 0.76 (0.54–1.08)
5 316 0.71 (0.51–0.98) 0.72 (0.52–0.99) 0.75 (0.54–1.05)
P for trend 0.22 0.27 0.48
Tangible support subscale4
Q1 179 Reference Reference Reference
Q2 182 1.00 (0.81–1.24) 1.01 (0.82–1.24) 1.01 (0.81–1.24)
Q3 114 1.07 (0.84–1.36) 1.07 (0.84–1.36) 1.11 (0.87–1.41)
Q4 197 0.93 (0.76–1.15) 0.95 (0.77–1.17) 0.97 (0.78–1.20)
P for trend 0.74 0.81 0.87
Positive social interaction subscale4
Q1 190 Reference Reference Reference
Q2 238 1.03 (0.84–1.25) 1.04 (0.85–1.26) 1.12 (0.92–1.37)
Q3 55 0.98 (0.72–1.33) 1.01 (0.74–1.38) 1.02 (0.74–1.40)
Q4 189 0.93 (0.75–1.14) 0.94 (0.76–1.16) 1.00 (0.81–1.24)
P for trend 0.52 0.63 0.93
DataareHR (95%CI) unlessotherwise indicated. 1Adjusted for ageatbaseline, race/ethnicity (American IndianorAlaskaNative,AsianorPacific Islander,
black or African American, Hispanic/Latino, non-Hispanic white, and other), education (high school or less, some college/technical training, college or
somepostcollege, andmaster’sdegreeorhigher), familyhistoryofMI (noor yes),hypertension (never,untreated,or treated), highcholesterol requiring
pills ever (no or yes), and different study cohorts (participation inOS or CTs anddifferent treatment assignments for all three CTs). 2Further adjusted for
depressive symptoms. 3Further adjusted for BMI, WHR, smoking (never, former, or current), alcohol intake (nondrinker, past drinker, current and,7
drinks/week, or current and $7 drinks/week), physical activity (,5, 5 to ,10, 10 to ,20, 20 to ,30, and $30 MET-h/week), and quality of diet
(quartile). 4Q1,Q2,Q3,andQ4 foreachexposure representfirst, second, third, and fourthquartile, respectively. 5Theaffectionsupport subscale isbased
on one question (question 9: someone to love you and make your feel wanted). See Supplementary Table 1A.
In conclusion, among postmenopausal
womenwith type 2 diabetes, larger social
network size and being married or in an
intimate relationship were associated
with decreased risk of CHD. A higher level
of stressful life events was associated with
increased risk of CHD. Our study has some
practical implications for targeted diabetic
care among postmenopausal women with
type2diabetes.Womenwithtype2diabetes
who experience stressful life events might
benefit from cognitive and behavioral ther-
apies to better cope with stressful events.
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